| Active substance |
Lisinopril |
| Also known as |
Losartan Potassium |
| Blood pressure |
Effectively reduces high blood pressure |
| Chemical name |
2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol |
| Classification |
Angiotensin-converting Enzyme (ACE) Inhibitors |
| Dosage (medical) |
Typically starts at 50 mg once daily, can increase to 100 mg once daily depending on the patient's response and condition |
| Dosage (sports) |
Not applicable as it is not used for performance enhancement |
| Effects |
Lowers blood pressure, reduces the risk of stroke in patients with high blood pressure and left ventricular hypertrophy |
| Formula |
C22H23ClN6O |
| Half-life |
1.5 to 2 hours, but the active metabolite has a half-life of 6 to 9 hours |
| Hepatotoxicity |
Rare |
| Lab Test |
Blood pressure monitoring, renal function tests |
| Main action |
Lowers blood pressure by blocking the receptors that angiotensin II acts on |
| Side effects |
Dizziness, light-headedness, nasal congestion, back pain, and fatigue |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Angiotensin II receptor blocker (ARB) |
| Trade name |
Cozaar |
| Use in sports |
None, as it does not enhance athletic performance |
| WAREHOUSE |
International Warehouse 1 |
| Water Retention |
Minimal to none |
| Manufacturer |
Healing Pharma |
